A detailed history of International Biotechnology Trust PLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, International Biotechnology Trust PLC holds 19,900 shares of PTGX stock, worth $947,638. This represents 0.11% of its overall portfolio holdings.

Number of Shares
19,900
Previous 19,900 -0.0%
Holding current value
$947,638
Previous $549,000 39.71%
% of portfolio
0.11%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

BUY
$18.02 - $29.36 $358,598 - $584,264
19,900 New
19,900 $549,000
Q2 2022

Aug 16, 2022

BUY
$7.06 - $25.52 $903 - $3,266
128 New
128 $16.2 Million
Q3 2021

Nov 12, 2021

SELL
$12.95 - $49.69 $1.97 Million - $7.55 Million
-152,000 Closed
0 $0
Q3 2020

Dec 01, 2020

BUY
$15.19 - $22.4 $2.31 Million - $3.4 Million
152,000 New
152,000 $2.97 Million

Others Institutions Holding PTGX

About Protagonist Therapeutics, Inc


  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2.34B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.